33 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
accounting firm the results of the annual audit and the review of our quarterly financial statements;
approves the retention of the independent … reports to be filed with the SEC;
reviews our critical accounting policies and estimates;
establishes procedures for the receipt, retention
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
and appropriate incentives and retention tools remains strong. The Offer will also allow our directors to be fairly compensated for their service on our Board
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
employees, the need for adequate and appropriate incentives and retention tools remains strong. The Offer will also allow our non-employee directors … and retain our employees. In the face of a competitive market for exceptional employees, the need for adequate and appropriate incentives and retention
S-3
EX-4.4
glsvabyizt2ps
4 Nov 21
Shelf registration
4:57pm
S-3
EX-1.2
389a96ne3cf0jg
4 Nov 21
Shelf registration
4:57pm
424B4
pmqvbu8
1 Jul 21
Prospectus supplement with pricing info
4:31pm